A group of top pharmaceutical companies have teamed up to develop diagnostic tests to identify patients at risk of dangerous adverse drug reactions. The Serious Adverse Events Consortium (SAEC), which includes Abbott, GlaxoSmithKline, Johnson & Johnson, Pfizer, Roche, sanofi-aventis and Wyeth, will begin by searching for genetic links to severe liver toxicity and the dangerous skin condition known as Stevens-Johnson syndrome. (11/20/2007)

In the UK, the government is talking about how to introduce more choice into healthcare for individuals, says John Procter, head of UK Pfizer Health Solutions and speaker at eyeforpharma’s recent conference on changes in the UK’s National Health Service (NHS). (10/9/2007)

According to a recent study by Gorman Health Group, universal electronic prescribing of medications for patients on Medicare could generate major benefits for the health-care industry and the patients it serves. The Institute of Medicine (IOM) has recommended a system-wide adoption of e-prescribing by 2010. (9/4/2007)

Jay Bolling, president of Roska Healthcare Advertising, believes that target marketing can help pharmas improve patient compliance - and the industry's image. (5/27/2007)